Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After Nephrectomy
A clinical trial is investigating whether contrast-enhanced ultrasound and super-resolution imaging can predict renal function outcomes afte…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study of Toripalimab in Adjuvant Therapy After Resection of High-risk Renal Cancer [Phase 2]
Phase 2 study evaluating toripalimab as adjuvant therapy after surgical resection of high-risk renal cell carcinoma.
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Targeted Abdominal CT in Conjunction With Lung Cancer Screening [NA]
University of Cambridge is recruiting for a study evaluating targeted abdominal CT in conjunction with lung cancer screening. The conditions…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Metastatic Renal Cell Carcinoma [NA]
A terminated clinical trial evaluating non-contrast arterial spin-labeled MRI to assess therapy response in metastatic renal cell carcinoma;…
-
CLINICAL_TRIALS withdrawal · 2025-12-19Clinical Trial Update: Time Restricted Eating (TRE) in Metastatic Head and Neck Squamous Cell Cancer (mHNSCC) or Unresectable or Metastatic Renal Cell Carcinoma (RCC) [NA]
A clinical trial investigating time-restricted eating in metastatic head and neck squamous cell carcinoma and unresectable or metastatic ren…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: A Study of Belzutifan (MK-6482) as Monotherapy and in Combination With Lenvatinib (E7080/MK-7902) With or Without Pembrolizumab (MK-3475) in China Participants With Advanced Renal Cell Carcinoma (MK-6482-010) [Phase 1]
Phase 1 study of belzutifan as monotherapy and in combination with lenvatinib, with or without pembrolizumab, in Chinese participants with a…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of INBRX-106 in combination with pembrolizumab for locally advanced or metastatic sol…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors [Phase 1]
Clinical trial update for a Phase 1 study evaluating the safety and pharmacokinetics of ADU-1805 in adults with advanced solid tumors; the s…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating axitinib with or without the anti-OX40 antibody PF-04518600 for metastatic renal cell carcinoma, currently active a…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Stereotactic Body RadioTherapy With Continuous Tracking for Primary and Secondary Renal Cancer [NA]
A ClinicalTrials.gov registry entry for a trial evaluating stereotactic body radiotherapy with continuous tracking for primary and metastati…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors [Phase 3]
Phase 3 trial evaluating the duration of PD-1/PD-L1 inhibitor therapy in advanced solid tumors; the study has completed.
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Iparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic Therapy [Phase 2]
Phase 2 clinical trial update evaluating iparomlimab and tuvonralimab in combination with lenvatinib or axitinib for locally advanced or met…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
A prospective cohort study led by Jinling Hospital in China is evaluating renal cancer monitoring through ctDNA methylomics, with recruitmen…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT [Phase 2]
A Phase 2 multicenter randomized trial evaluating finerenone and empagliflozin to delay renal function decline after radical nephrectomy in …
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney Cancer. [NA]
This clinical trial update describes a personalized six-month program aimed at reducing frailty in older patients treated for bladder cancer…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer [Phase 1]
Phase 1 study of aldesleukin in combination with pembrolizumab in advanced or metastatic renal cell carcinoma has been terminated with resul…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Vorolanib is being studied in a second-line trial for unresectable or metastatic renal cell carcinoma, with recruitment ongoing in China.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Abscopal Effect of Ultra-Hypofractionated Radiation Plus Immunotherapy in Metastatic Renal Cell Carcinoma
This clinical trial update reports on a study evaluating the abscopal effect of ultra-hypofractionated radiation plus immunotherapy in metas…
-
EMA approval · 2025-12-04EMA Authorised: Sunitinib Accord (sunitinib) — Accord Healthcare S.L.U.
The European Medicines Agency authorised Sunitinib Accord for the treatment of gastrointestinal stromal tumors, renal cell carcinoma, and ne…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy
This completed clinical trial evaluates the feasibility of a smartphone app for patients with advanced renal cell carcinoma undergoing combi…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: The Pharmacokinetic Variability of Sunitinib in Patients With Metastatic Renal Cancer
A completed clinical trial update assessing the pharmacokinetic variability of sunitinib in patients with metastatic renal cancer.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma [Phase 2]
This is a Phase 2 clinical trial update evaluating stereotactic body radiation therapy for oligoprogression in metastatic renal cell carcino…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program [Phase 2]
Phase 2 trial evaluating in-home versus in-clinic subcutaneous nivolumab administration under the CC Beyond Walls program; the study is curr…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: [18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma [Phase 1]
Phase 1 clinical trial evaluating [18F]PT2385 PET/CT in renal cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma [Phase 2]
A Phase II trial of nivolumab plus ipilimumab in patients with Renal Medullary Carcinoma has been terminated, with the study status updated.